Halozyme Therapeutics Inc (FRA:RV7)
€ 40.96 -0.64 (-1.54%) Market Cap: 5.26 Bil Enterprise Value: 6.22 Bil PE Ratio: 18.58 PB Ratio: 32.17 GF Score: 81/100

Halozyme Therapeutics Inc (FRA:RV7) Transcripts

  • 1